Tech Leaders Urge Pentagon to Reconsider Anthropic Supply-Chain Risk Designation

Hundreds of technology professionals have signed an open letter calling on the U.S. Department of Defense to withdraw its designation of Anthropic as a supply-chain risk and urging Congress to review the use of such authorities against an American AI company. Signatories include employees and investors affiliated with OpenAI, Slack, IBM, Cursor, and Salesforce Ventures, among others.

The appeal follows a breakdown in negotiations between Anthropic and the Pentagon after Chief Executive Officer Dario Amodei declined to permit unrestricted military use of the company’s AI systems, maintaining prohibitions on mass domestic surveillance and fully autonomous weapons. President Donald Trump subsequently directed federal agencies to phase out Anthropic technology, and Defense Secretary Pete Hegseth announced the supply-chain risk designation, though formal review procedures remain pending.

Industry voices, including OpenAI researcher Boaz Barak, said concerns about potential government misuse of AI and called for safeguards comparable to those applied to other high-risk domains.

Featured image: Credit: Wikipedia

Need Deeper Intelligence on the AI Market?

AI Insider's Market Intelligence platform tracks funding rounds, competitive landscapes, and technology trends across the global AI ecosystem in real time. Get the data and insights your organization needs to make informed decisions.

Related Articles

Amazon Launches Agentic AI Assistant ‘Alexa for Shopping’

Insider Brief Amazon is rolling out a new AI-powered shopping assistant called Alexa for Shopping that combines conversational AI, personalized recommendations and automation tools across

Autonomous Defense Tech Company Anduril Announces $5B Series H Funding Round

Insider Brief Defense technology company Anduril Industries has raised $5 billion in a Series H funding round to expand manufacturing capacity and autonomous defense systems

Global AI Life Sciences
Study Finds AI Competitiveness in Life Sciences Depends on Data, Regulation And Capital

Insider Brief Artificial intelligence is moving from laboratory experiments into the core infrastructure of drug discovery, healthcare delivery and preventive medicine, according to a new

Stay Updated with AI Insider

Get the latest AI funding news, market intelligence, and industry insights delivered to your inbox weekly.

$ 0 M

Seed round tracked

Gitar — Code Validation

Get the Weekly Briefing

Funding analysis, market intelligence, and industry trends delivered to your inbox every week.

Need bespoke intelligence?

Our team combines real-time data with decades of sector experience to guide your decisions.

Subscribe today for the latest news about the AI landscape